SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000921895-16-005018
Filing Date
2016-06-27
Accepted
2016-06-27 19:35:26
Documents
1
Period of Report
2016-06-23

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form407422021_06272016.html 4  
1 OWNERSHIP DOCUMENT form407422021_06272016.xml 4 44482
  Complete submission text file 0000921895-16-005018.txt   49395
Mailing Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104
Business Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Reporting) CIK: 0000918923 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-33882 | Film No.: 161734464
SIC: 6282 Investment Advice

Mailing Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104
Business Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104 3125066500
BVF PARTNERS L P/IL (Reporting) CIK: 0001055947 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33882 | Film No.: 161734465

Mailing Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104
Business Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104 3125066500
BVF INC/IL (Reporting) CIK: 0001056807 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-33882 | Film No.: 161734467

Mailing Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104
Business Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND II LP (Reporting) CIK: 0001102444 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-33882 | Film No.: 161734470

Mailing Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104
Business Address
LAMPERT MARK N (Reporting) CIK: 0001233840 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33882 | Film No.: 161734466

Mailing Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121
Business Address 2601 FOURTH AVENUE SUITE 500 SEATTLE WA 98121 (206) 801-2100
Cascadian Therapeutics, Inc. (Issuer) CIK: 0001412067 (see all company filings)

IRS No.: 260868560 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address P.O. BOX 309 UGLAND HOUSE GRAND CAYMAN E9 KY1-1104
Business Address P.O. BOX 309 UGLAND HOUSE GRAND CAYMAN E9 KY1-1104 (415) 525-8890
Biotechnology Value Trading Fund OS LP (Reporting) CIK: 0001660683 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-33882 | Film No.: 161734469

Mailing Address P.O. BOX 309 UGLAND HOUSE GRAND CAYMAN E9 KY1-1104
Business Address P.O. BOX 309 UGLAND HOUSE GRAND CAYMAN E9 KY1-1104 (415) 525-8890
BVF Partners OS Ltd. (Reporting) CIK: 0001660684 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-33882 | Film No.: 161734468